Ovarian cancer
Results
Phase 2
This trial looked at whether the CA125 blood test was a reliable way to measure if new treatments for ovarian cancer were working or not. This trial was supported by Cancer Research UK.
The trial was for women who had
These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all of these.
Recruitment start: 1 December 2003
Recruitment end: 27 November 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Rustin
Cancer Research UK
East and North Hertfordshire NHS Trust
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKE/04/014.
Last reviewed: 25 Nov 2013
CRUK internal database number: 544